Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018

Authors :: Yasuo Takiguchi
Takeharu Yamanaka
Yusuke Nakamura
Kazuma Kishi
Terufumi Kato
Haruhiro Saito
Hiroaki Okamoto
Kaoru Kubota
Hiroshi Tanaka
Satoshi Igawa
Tsuneo Shimokawa
Kazuhiko Yamada
Takashi Kasai
Yukio Hosomi
Naoyuki Nogami
Source :: Annals of Oncology. 29:viii491
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Cisplatin
Oncology
medicine.medical_specialty
business.industry
Thoracic radiotherapy
Hematology
Stage III Non-Small Cell Lung Cancer
03 medical and health sciences
0302 clinical medicine
Docetaxel
030220 oncology & carcinogenesis
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools